Protamine/RNA nanoparticles for immunostimulation

作者: Alexander Knuth , Steve Pascolo

DOI:

关键词:

摘要: The present invention relates to protamine/RNA nanoparticles of defined average size, a pharmaceutical composition containing said and method producing the same. is particularly useful as an immunostimulating medicament with precise pattern immunostimulation different from prior art.

参考文章(6)
John M. Yanni, Daniel A. Gamache, Jon E. Chatterton, Steven T. Miller, RNAi-MEDIATED INHIBITION OF SPLEEN TYROSINE KINASE-RELATED INFLAMMATORY CONDITIONS ,(2007)
Ingmar Dr. Hoerr, Der MüLBE Florian Von, Steve Dr. Pascolo, Stabilised mrna tumour vaccine ,(2002)
Shyh-Dar Li, Leaf Huang, Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. Molecular Pharmaceutics. ,vol. 3, pp. 579- 588 ,(2006) , 10.1021/MP060039W
Ingmar Hoerr, Reinhard Obst, Hans-Georg Rammensee, Günther Jung, In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies. European Journal of Immunology. ,vol. 30, pp. 1- 7 ,(2000) , 10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-#
Jörg Weyermann, Dirk Lochmann, Christiane Georgens, Andreas Zimmer, Albumin-protamine-oligonucleotide-nanoparticles as a new antisense delivery system. Part 2: cellular uptake and effect. European Journal of Pharmaceutics and Biopharmaceutics. ,vol. 59, pp. 431- 438 ,(2005) , 10.1016/J.EJPB.2004.07.014
Florian Von Der MüLBE, Ingmar Dr. Hoerr, Steve Dr. Pascolo, Transfection of blood cells with mRNA for immune stimulation and gene therapy ,(2004)